Detalhe da pesquisa
1.
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.
J Hepatol
; 65(3): 490-8, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27132170